JINGHAO MEDICAL
872925
TONGYI AEROSPACE
871642
ESKONJAC
839273
4
Jiangsu Olive Sensors High-Tech
300507
5
Jing-Jin Electric Technologies
688280
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.2224
- -0.0034-1.51%
Close May 6 16:00 ET
- 0.2351
- +0.0127+5.71%
Pre 08:24 ET
9.29MMarket Cap-0.15P/E (TTM)
0.2440High0.2200Low538.78KVolume0.2200Open0.2258Pre Close127.41KTurnover1.73%Turnover RatioLossP/E (Static)41.79MShares1.900052wk High-0.33P/B6.93MFloat Cap0.160152wk Low--Dividend TTM31.15MShs Float51.3573Historical High--Div YieldTTM10.63%Amplitude0.1601Historical Low0.2360Avg Price1Lot Size
Carisma Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -76.92%17.91M | -76.92%17.91M | -71.44%26.88M | -65.53%40.36M | -59.33%56.52M | 49.25%77.61M | 49.25%77.61M | --94.14M | 43.47%117.08M | --138.97M |
| -Cash and cash equivalents | -76.92%17.91M | -76.92%17.91M | -67.66%26.88M | -47.14%40.36M | -9.97%56.52M | 220.76%77.61M | 220.76%77.61M | --83.13M | 92.33%76.35M | --62.78M |
| -Short-term investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --11.01M | -2.82%40.73M | --76.19M |
| Prepaid assets | ---- | ---- | --1.25M | --1.55M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 106.42%5.92M | 106.42%5.92M | 75.26%6.01M | 72.02%8.81M | -19.82%4.44M | 10.40%2.87M | 10.40%2.87M | --3.43M | 100.16%5.12M | --5.54M |
| Total current assets | -70.39%23.83M | -70.39%23.83M | -65.01%34.14M | -58.49%50.72M | -57.82%60.95M | 47.40%80.47M | 47.40%80.47M | --97.57M | 45.19%122.2M | --144.5M |
| Non current assets | ||||||||||
| Net PPE | -28.11%6.43M | -28.11%6.43M | -14.71%7.71M | -20.32%8.48M | 9.48%12.7M | -33.55%8.94M | -33.55%8.94M | --9.04M | -19.39%10.64M | --11.6M |
| -Gross PPE | -5.14%14.31M | -5.14%14.31M | -14.71%7.71M | -20.32%8.48M | 9.48%12.7M | -10.00%15.09M | -10.00%15.09M | --9.04M | -29.53%10.64M | --11.6M |
| -Accumulated depreciation | -28.22%-7.89M | -28.22%-7.89M | ---- | ---- | ---- | -85.61%-6.15M | -85.61%-6.15M | ---- | ---- | ---- |
| Non current deferred assets | 42.47%208K | 42.47%208K | 42.47%208K | -2.74%142K | --142K | -96.45%146K | -96.45%146K | --146K | --146K | --0 |
| Other non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30K | --30K | --30K |
| Total non current assets | -26.97%6.63M | -26.97%6.63M | -14.08%7.92M | -20.30%8.62M | 10.42%12.84M | -48.28%9.08M | -48.28%9.08M | --9.22M | -18.05%10.81M | --11.63M |
| Total assets | -65.99%30.46M | -65.99%30.46M | -60.61%42.06M | -55.39%59.34M | -52.74%73.8M | 24.12%89.55M | 24.12%89.55M | --106.78M | 36.62%133.01M | --156.13M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -47.09%2.08M | -47.09%2.08M | -33.69%1.73M | -18.25%2.03M | -53.06%2.17M | 127.60%3.93M | 127.60%3.93M | --2.61M | -35.70%2.49M | --4.61M |
| -accounts payable | -47.09%2.08M | -47.09%2.08M | -28.27%1.73M | -18.25%2.03M | -53.06%2.17M | 127.60%3.93M | 127.60%3.93M | --2.41M | -35.70%2.49M | --4.61M |
| -Total tax payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --197K | ---- | ---- |
| Current accrued expenses | -43.69%2.57M | -43.69%2.57M | -55.59%2.24M | -65.99%3.27M | -62.23%3.85M | -39.59%4.56M | -39.59%4.56M | --5.04M | 141.13%9.61M | --10.19M |
| Current debt and capital lease obligation | -10.23%1.74M | -10.23%1.74M | 77.23%2.46M | 85.65%6.87M | 2.09%3.86M | -57.93%1.94M | -57.93%1.94M | --1.39M | -23.80%3.7M | --3.79M |
| -Current capital lease obligation | -10.23%1.74M | -10.23%1.74M | 77.23%2.46M | 85.65%6.87M | 2.09%3.86M | -57.93%1.94M | -57.93%1.94M | --1.39M | -23.80%3.7M | --3.79M |
| Current deferred liabilities | 163.91%3.73M | 163.91%3.73M | -42.45%682K | -53.46%659K | -44.34%1.19M | -42.54%1.41M | -42.54%1.41M | --1.19M | 216.78%1.42M | --2.14M |
| Other current liabilities | 9.84%1.06M | 9.84%1.06M | 21.53%1.15M | 61.85%1.22M | 58.01%1.19M | 84.51%965K | 84.51%965K | --943K | --755K | --755K |
| Current liabilities | 0.92%16.06M | 0.92%16.06M | -18.48%10.56M | -13.11%15.62M | -38.81%13.14M | -19.13%15.91M | -19.13%15.91M | --12.95M | 36.58%17.97M | --21.48M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -37.37%744K | -37.37%744K | -36.94%857K | -15.01%1.3M | 114.93%3.63M | -96.66%1.19M | -96.66%1.19M | --1.36M | -95.62%1.53M | --1.69M |
| -Long term capital lease obligation | -37.37%744K | -37.37%744K | -36.94%857K | -15.01%1.3M | 114.93%3.63M | -35.71%1.19M | -35.71%1.19M | --1.36M | -35.86%1.53M | --1.69M |
| Non current deferred liabilities | -8.33%41.25M | -8.33%41.25M | -8.33%41.25M | -8.33%41.25M | 0.00%45M | 0.00%45M | 0.00%45M | --45M | 0.00%45M | --45M |
| Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Preferred securities outside stock equity | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Other non current liabilities | -65.66%318K | -65.66%318K | -55.87%519K | -54.95%815K | -40.38%1.13M | -11.05%926K | -11.05%926K | --1.18M | --1.81M | --1.9M |
| Total non current liabilities | -10.19%42.31M | -10.19%42.31M | -10.33%42.63M | -10.29%43.36M | 2.42%49.76M | -75.86%47.11M | -75.86%47.11M | --47.54M | -42.72%48.34M | --48.59M |
| Total liabilities | -7.39%58.37M | -7.39%58.37M | -12.07%53.18M | -11.05%58.98M | -10.22%62.9M | -70.66%63.02M | -70.66%63.02M | --60.49M | -32.02%66.31M | --70.06M |
| Shareholders'equity | ||||||||||
| Share capital | 2.50%41K | 2.50%41K | 2.50%41K | 2.50%41K | 2.50%41K | 1,900.00%40K | 1,900.00%40K | --40K | -99.96%40K | --40K |
| -common stock | 2.50%41K | 2.50%41K | 2.50%41K | 2.50%41K | 2.50%41K | 1,900.00%40K | 1,900.00%40K | --40K | --40K | --40K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- | ---- | ---- |
| Retained earnings | -24.67%-305.58M | -24.67%-305.58M | -28.46%-287.94M | -35.76%-275.24M | -44.41%-264.08M | -54.91%-245.1M | -54.91%-245.1M | ---224.14M | -64.62%-202.74M | ---182.87M |
| Paid-in capital | 2.22%277.63M | 2.22%277.63M | 2.50%276.78M | 2.39%275.56M | 2.30%274.93M | 22,589.56%271.59M | 22,589.56%271.59M | --270.03M | 27,790.26%269.14M | --268.76M |
| Gains losses not affecting retained earnings | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --373K | 234.52%265K | --136K |
| Total stockholders'equity | -205.19%-27.91M | -205.19%-27.91M | -124.03%-11.13M | -99.46%360K | -87.34%10.9M | 116.89%26.53M | 116.89%26.53M | --46.3M | 557.48%66.71M | --86.07M |
| Noncontrolling interests | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 | --0 |
| Total equity | -205.19%-27.91M | -205.19%-27.91M | -124.03%-11.13M | -99.46%360K | -87.34%10.9M | 118.60%26.53M | 118.60%26.53M | --46.3M | 35,962.90%66.71M | --86.07M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀